201 related articles for article (PubMed ID: 23705857)
1. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
[TBL] [Abstract][Full Text] [Related]
2. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
[TBL] [Abstract][Full Text] [Related]
3. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling.
Khanfar MA; Al-Qtaishat S; Habash M; Taha MO
Chem Biol Interact; 2016 Jul; 254():93-101. PubMed ID: 27216633
[TBL] [Abstract][Full Text] [Related]
5. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
[TBL] [Abstract][Full Text] [Related]
7. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
[TBL] [Abstract][Full Text] [Related]
8. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor.
Hsiao PY; Kalin JH; Sun IH; Amin MN; Lo YC; Chiang MJ; Giddens J; Sysa-Shah P; Gabrielson K; Wang LX; Powell JD; Cole PA
Chembiochem; 2016 Oct; 17(20):1951-1960. PubMed ID: 27432157
[TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]ZM 241385 binding in wild-type and adenosine A2A receptor knockout mice.
Kelly M; Bailey A; Ledent C; Kitchen I; Hourani S
Eur J Pharmacol; 2004 Nov; 504(1-2):55-9. PubMed ID: 15507221
[TBL] [Abstract][Full Text] [Related]
10. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
Pang X; Yang M; Han K
Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
[TBL] [Abstract][Full Text] [Related]
11. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
[TBL] [Abstract][Full Text] [Related]
12. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
13. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A
Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V
J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753
[TBL] [Abstract][Full Text] [Related]
14. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
16. The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design.
Jaakola VP; Ijzerman AP
Curr Opin Struct Biol; 2010 Aug; 20(4):401-14. PubMed ID: 20538452
[TBL] [Abstract][Full Text] [Related]
17. Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study.
Moro S; Braiuca P; Deflorian F; Ferrari C; Pastorin G; Cacciari B; Baraldi PG; Varani K; Borea PA; Spalluto G
J Med Chem; 2005 Jan; 48(1):152-62. PubMed ID: 15634009
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
[TBL] [Abstract][Full Text] [Related]
19. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
Zeng L; Guan M; Jin H; Liu Z; Zhang L
Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]